Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bulk dex bill passes house

This article was originally published in The Tan Sheet

Executive Summary

The House passed Michigan Republican Fred Upton's legislation, H.R. 970, to crack down on the bulk sale of dextromethorphan and prevent its abuse. "The Dextromethorphan Distribution Act of 2007" makes it illegal to sell unfinished DXM to any person or company not registered with FDA. The Senate received the bill Oct. 16 and referred it to the Health Committee. A similar bill passed in December 2006, but the Senate did not act on it. Upton recently called on the Senate to pass the measure (1"The Tan Sheet" Oct. 1, 2007, p. 5). The bill is endorsed by the American Pharmacists Association, Consumer Healthcare Products Association, Food Marketing Institute, National Association of Chain Drug Stores and The Partnership for a Drug-Free America...

You may also be interested in...

House DXM Bill Sponsor Expects Senate To Approve Measure This Year

Michigan Congressman Fred Upton says he expects to see a bill to restrict online sales of bulk dextromethorphan to entities registered with FDA pass this year

Health And Wellness Trademark Review 14 January, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention

Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts